n,n-dimethylarginine has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buijs, N; Geller, DA; Houdijk, AP; Jessup, M; Oosterink, JE; Schierbeek, H; Stolz, DB; van Leeuwen, PA | 1 |
| Dasari, C; Duscharla, D; Kumar, JM; Ram, NS; Reddy, KRK; Supriya, B; Surekha, MV; Ummanni, R | 1 |
| Kulwas, A; Rość, D; Wieczór, AM; Wieczór, R | 1 |
| Dasari, C; Jadav, SS; Kami Reddy, KR; Kumar, JM; Natani, S; Sai Ram, N; Supriya, B; Ummanni, R; Vandavasi, S | 1 |
| Bauersachs, J; Ertl, G; Fiedler, J; Fleissner, F; Galuppo, P; Gupta, SK; Jazbutyte, V; Kneitz, S; Mayr, M; Thum, T; Xu, Q; Yin, X | 1 |
| Fialka-Moser, V; Giurgea, A; Gröger, M; Gschwandtner, M; Hammer, A; Koppensteiner, R; Schlager, O; Schuhfried, O; Seidinger, D; Steiner, S | 1 |
| Boult, JK; Jamin, Y; Leiper, JM; Robinson, SP; Walker-Samuel, S; Whitley, GS | 1 |
| Singh, JP | 1 |
| Allanore, Y; Avouac, J; Boileau, C; Borderie, D; Kahan, A; Lemarechal, H; Wipff, J; Zerkak, D | 1 |
2 review(s) available for n,n-dimethylarginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Asymmetric dimethylarginine and angiogenesis: biological significance.
Topics: Animals; Arginine; Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; Plaque, Atherosclerotic; Signal Transduction; Up-Regulation | 2018 |
Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
Topics: Amidohydrolases; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Arginine; Endothelium, Vascular; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III | 2007 |
1 trial(s) available for n,n-dimethylarginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial.
Topics: Aged; Arginine; Cell Movement; Chemokine CXCL12; Endothelial Cells; Exercise; Female; Flow Cytometry; Humans; Intermittent Claudication; Male; Middle Aged; Neovascularization, Pathologic; Peripheral Arterial Disease; Stem Cells; Time Factors; Vascular Endothelial Growth Factor A | 2011 |
6 other study(ies) available for n,n-dimethylarginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
Topics: Aged; Amidohydrolases; Arginine; Carcinoma, Hepatocellular; Cell Hypoxia; Female; Hep G2 Cells; Humans; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Vascular Endothelial Growth Factor A | 2017 |
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Topics: Amidohydrolases; Animals; Arginine; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; PC-3 Cells; Platelet Endothelial Cell Adhesion Molecule-1; Prostatic Neoplasms; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A | 2018 |
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
Topics: Amidohydrolases; Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokines; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Nude; Molecular Docking Simulation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Prostatic Neoplasms; Pyridines; Signal Transduction; Transcription Factors; Vascular Endothelial Growth Factor A | 2019 |
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism.
Topics: Angiogenesis Inhibitors; Arginine; Coronary Artery Disease; Gene Expression Regulation; Humans; MicroRNAs; Neovascularization, Pathologic; Stem Cells | 2010 |
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
Topics: Amidohydrolases; Animals; Arginine; Catalytic Domain; Female; Glioma; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Mutation; Neoplasm Transplantation; Neovascularization, Pathologic; Phenotype; Rats; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Cross-Sectional Studies; Endoglin; Female; Humans; Male; Middle Aged; Neovascularization, Pathologic; Receptors, Cell Surface; Scleroderma, Systemic; Solubility; Vascular Endothelial Growth Factor A | 2008 |